Document Type
Article
Publication Date
September 2025
Patent Number
12414972
Abstract
The present disclosure provides for a method of treating increased gut permeability, including administering a therapeutically effective amount of a human-derived probiotic to a patient in need thereof. Further provided herein is a method of increasing a patient's metabolism of ethanolamine, including administering a therapeutically effective amount of human derived probiotics to the patient in need thereof. Also provided herein is a pharmaceutical composition, including a first strain of Lactobacillus and a second probiotic strain. The present disclosure also provides for a pharmaceutical composition, including Lactobacillus and an antidiabetic drug. Additionally, provided herein is a pharmaceutical composition, including Lactobacillus and a weight management drug.
Application Number
17/973909
Recommended Citation
Yadav, Hariom; Jain, Shalini; and Mishra, Sidharth, "Human origin probiotic lactobacillus rhamnosus HL-200 to reduce leaky gut by metabolizing ethanolamine" (2025). USF Patents. 1526.
https://digitalcommons.usf.edu/usf_patents/1526
Assignees
University of South Florida
Filing Date
10/26/2022
